The Tumor Models Conference Series is dedicated to exploring the latest advances in the application of preclinical models to enhance the translation of cancer therapies from bench to patient.
Merging its unique strategic focus and scientific quality of presentations, the event facilitates an environment of knowledge sharing and debate to actively assess how the industry is overcoming challenges in drug development through the use of in vitro & in vivo models.
As 2018 comes to a close, make sure you don’t miss out on the most trusted and assured meeting dedicated to helping you predict the clinical outcome of your drug candidates more accurately.
CHECK OUT THIS YEARS AGENDA HERE:
3 Top Highlights from Tumour Models 2017:
PART OF TUMOR MODELS SERIES